11
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8944 |
TTA-A2
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
TTA-A2 是一种选择性 T 型钙通道拮抗剂,是一种有效的抗惊厥药,可减少孕烷 X 受体的激活。它对 Cav3.1 (a1G) 和 Cav3.2 (a1H) 通道在 -80 mV 和- 100 mV 保持电位上具有同样的作用,IC50 值分别为 89 和 92 nM。它可用于多种人类神经系统疾病的研究,包括睡眠障碍和癫痫。 | |||
T12076 |
ML218 hydrochloride
|
Others | Others |
ML218 hydrochloride is a selective and orally active T-type Ca2+ channels (Cav3.1, Cav3.2, Cav3.3) inhibitor (Cav3.2 and Cav3.3 with IC50s of 310 nM and 270 nM , respectively). | |||
T63350 | Cav 3.2 inhibitor 3 | ||
Cav 3.2 inhibitor 3 是 Cav3.2 T-type Ca2+channel 的有效抑制剂 (IC50: 0.1534 μM),且对 D2受体的结合亲和力很低。 | |||
T62586 |
Cav 2.2/3.2 blocker 1
|
||
Cav 2.2/3.2 blocker 1 (Compound 9e) 是一种神经钙离子通道 (neuronal calcium channel) 阻断剂,能够作用于 Cav2.2 (IC50: 1.22 μM) 和 Cav3.2 (IC50: 80 μM)。Cav 2.2/3.2 blocker 1 可以穿透中枢神经系统。 | |||
T12076L |
ML218
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
ML218 是一种具有口服活性、选择性、高效性且可穿透血脑屏障的 T 型 Ca2+ 通道抑制剂(Cav3.2 和 Cav3.3 的 IC50 分别为 310 nM 和 270 nM)。ML218 可抑制丘脑下核(STN)神经元的突发性活动。 | |||
TP2003 |
Mambalgin 1
|
||
Selective ASIC1a inhibitor (IC50 values are 192 and 72 nM for human ASIC1a and ASIC1a/1b dimer, respectively). Binds to closed/inactive channel. Selective for ASIC1a over ASIC2a, ASIC3, TRPV1, P2X2, 5-HT3, Nav1.8, Cav3.2 and Kv1.2 channels. Increases late | |||
T75954 |
Mambalgin 1 TFA
|
||
Mambalgin 1 TFA, a selective inhibitor of ASIC1a (with IC50 values of 192 nM for human ASIC1a and 72 nM for the ASIC1a/1b dimer), preferentially binds to the channel in its closed/inactive state. It demonstrates selectivity for ASIC1a over a range of other channels, including ASIC2a, ASIC3, TRPV1, P2X2, 5-HT3, Nav1.8, Cav3.2, and Kv1.2. In vivo, Mambalgin 1 TFA effectively prolongs the latency of the withdrawal response in mouse tail-flick and paw-flick tests. | |||
T63606 | Cav 3.2 inhibitor 2 | ||
Cav 3.2 inhibitor 2 是一种 Cav3.2 T-type Ca2+channels 的抑制剂,-80mV 恒定电位下,其IC50=0.09339 μM。Cav 3.2 inhibitor 2 对小鼠 T 通道依赖性的躯体和内脏疼痛表现出有效的抑制作用。Cav 3.2 inhibitor 2 能够用于研究顽固性疼痛。 | |||
T64203 | T-Type calcium channel inhibitor 2 | ||
T-Type calcium channel inhibitor 2 (compound 6g) 是一种 T 型钙通道的有效抑制剂,能够作用于 Cav3.1 (α1G) (IC50: 31.0 μM)、Cav3.2 (α1H) (IC50: 83.1 μM)、Cav3.3 (α1I) (α1H) (IC50: 69.3 μM)。T-Type calcium channel inhibitor 2 对 A549、HCT-116 细胞表现出细胞毒性,IC50s 分别为5.0、6.4 μM。 | |||
T36070 |
(±)5(6)-EET
|
||
5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS. In neuroendocrine cells, such as the anterior pituitary and pancreatic islets, 5(6)-EET has been implicated in the mobilization of calcium and hormone secretion. 5(6)-EET is an inhibitor of T-type voltage-gated calcium channels (Cav3) that inhib... | |||
T79195 |
Cav 3.2 inhibitor 4
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Cav 3.2 inhibitor 4 (compound 21) 是高效的选择性 T 型钙通道 (Cav3.2) 抑制剂,具有外周限制性,其 IC50 值为 0.6 μM,适用于心房颤动研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0928 |
L-Ascorbic acid
维生素C,Vitamin C,Ascorbic acid,L(+)-Ascorbic acid,抗坏血酸,L-Ascorbate |
Apoptosis; Calcium Channel; Reactive Oxygen Species; Endogenous Metabolite | Apoptosis; Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; NF-κB |
L-Ascorbic acid (Vitamin C) 属于天然产物,是一种强效的还原剂和抗氧化剂。L-Ascorbic acid 具有抗细菌感染、解毒反应和胶原蛋白形成的作用。L-Ascorbic acid 被用于治疗坏血病。 | |||
T6674 |
L-Ascorbic acid sodium salt
(+)-Sodium L-ascorbate,Vitamin C sodium salt,Sodium ascorbate,L-Ascorbic acid sodium,抗坏血酸钠,Sodium L-ascorbate,维生素C钠 |
Apoptosis; Others; Calcium Channel; Reactive Oxygen Species; Endogenous Metabolite | Apoptosis; Immunology/Inflammation; Membrane transporter/Ion channel; Metabolism; NF-κB; Others |
L-Ascorbic acid sodium salt (Vitamin C sodium salt) 是一种电子供体,是一种内源性抗氧化剂。它还是一种胶原沉积促进剂和弹性生成抑制剂。它选择性抑制 Cav3.2 通道(Cav3.2 channels),IC50为 6.5 μM。 |